Onderzoeker
Hanne Vos
- Disciplines:Morfologische wetenschappen, Oncologie, Orthopedie, Heelkunde, Verpleegkunde
Affiliaties
- Oncologische Heelkunde (Afdeling)
Lid
Vanaf1 sep 2016 → Heden
Projecten
1 - 1 of 1
- Effect van pembrolizumab op biomarkers gerelateerd met intratumorale immuniteit, proliferatie en apoptose in vroege ER/PR negatieve borstkankerVanaf1 okt 2016 → 15 nov 2021Financiering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
Publicaties
1 - 10 van 12
- Obesity-associated changes in molecular biology of primary breast cancer(2023)
Auteurs: Ha Linh Nguyen, Tatjana Geukens, Maxim De Schepper, Stefan Naulaerts, Ines Nevelsteen, Patrick Neven, Karen Van Baelen, Hanne Vos, Hans Wildiers, Beppe Floris, et al.
- Capturing age-related changes in the tumor microenvironment of luminal breast cancer using the multiplex immunohistochemistry technique, MILAN.(2023)
Auteurs: Yentl Lambrechts, Maxim De Schepper, Tatjana Geukens, Hanne Vos, Julie Messiaen, Patrick Neven, Christine Desmedt, Francesca Bosisio, Frederik De Smet, Sigrid Hatse, et al.
- A pan-cancer single-cell tumor micro-environment atlas predictive of immunotherapy response(2023)
Auteurs: Sam Vanmassenhove, Pierre Van Mol, Sarah Cappuyns, Liselore Loverix, Hanne Vos, Diether Lambrechts
- Obesity-associated changes in transcriptomic profile and immune landscape of primary breast cancer revealed by bulk and single-cell gene expression data(2023)
Auteurs: Tatjana Geukens, Karen Van Baelen, Maxim De Schepper, Hanne Vos, Patrick Neven, Ines Nevelsteen, Hans Wildiers, Beppe Floris, Diether Lambrechts, François Richard, et al.
- Effect of pembrolizumab on biomarkers related to intratumoral immunity, proliferation and apoptosis in early breast cancer(2021)
Auteurs: Hanne Vos, Ann Smeets, Beppe Floris, Ines Nevelsteen
- Comparison of the tumor immune microenvironment of primary hormone receptor-negative HER2-positive and triple negative breast cancer(2021)
Auteurs: Hanne Vos, Kathleen Lambein, François Richard, Ines Nevelsteen, Kevin Punie, Hans Wildiers, Lieze Berben, Annouschka Laenen, Beppe Floris, Christine Desmedt, et al.
- Blood Immunosenescence Signatures Reflecting Age, Frailty and Tumor Immune Infiltrate in Patients with Early Luminal Breast Cancer(2021)
Auteurs: Lieze Berben, Cindy Kenis, Ann Smeets, Hanne Vos, Patrick Neven, Beppe Floris, Hans Wildiers, Sigrid Hatse
- A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer(2021)
Auteurs: Ayse Bassez, Hanne Vos, Laurien Van Dyck, Beppe Floris, Ingrid Arijs, Christine Desmedt, Bram Boeckx, Marlies Vanden Bempt, Ines Nevelsteen, Kathleen Lambein, et al.
Pagina's: 820 - + - Immune-related adverse events after a single dose of pembrolizumab(2021)
Auteurs: Hanne Vos, Kathleen Lambein, Hans Wildiers, Kevin Punie, Ann Smeets
Pagina's: 92 - 94 - A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling(2020)
Auteurs: Siel Olbrecht, Bram Boeckx, Hanne Vos, H. Emre Etlioglu, Els Wauters, Sara Verbandt, Pieter Busschaert, Ayse Bassez, Amelie Franken, Jieyi Xiong, et al.
Pagina's: 745 - 762